Register entry
- Registered sites
- 0
- Active NDC listings
- 14
- Labeller names
- 2
- Live patents
- 11
- Countries
- 0
Catalogue
Drug listings by form and route
1414 active NDC listings: 14 human prescription drug. By marketing category: ANDA 10, NDA AUTHORIZED GENERIC 3, NDA 1.
| Dosage form | NDCs |
|---|---|
| tablet | 4 |
| tablet, extended release | 3 |
| injection, solution | 2 |
| injection, solution, concentrate | 2 |
| solution | 2 |
| solution, concentrate | 1 |
| Route | NDCs |
|---|---|
| oral | 8 |
| intravenous | 3 |
| topical | 2 |
| intramuscular | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| omnivium pharmaceuticals llc. | 8 |
| omnivium pharmaceuticals llc | 6 |
Exclusivity
Patents and exclusivities
11| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10016407 | NUMBRINOcocaine hydrochloride | use | Feb 2037 |
| 10149843 | NUMBRINOcocaine hydrochloride | use | Feb 2037 |
| 10231961 | NUMBRINOcocaine hydrochloride | product | Feb 2037 |
| 10413505 | NUMBRINOcocaine hydrochloride | use | Feb 2037 |
| 10420760 | NUMBRINOcocaine hydrochloride | use | Feb 2037 |
| 10857095 | NUMBRINOcocaine hydrochloride | use | Feb 2037 |
| 10894012 | NUMBRINOcocaine hydrochloride | use | Feb 2037 |
| 10933060 | NUMBRINOcocaine hydrochloride | use | Feb 2037 |
| 10973811 | NUMBRINOcocaine hydrochloride | use | Feb 2037 |
| 11040032 | NUMBRINOcocaine hydrochloride | product | Feb 2037 |
| 9867815 | NUMBRINOcocaine hydrochloride | use | Feb 2037 |
Catalogue
Marketed products
14| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| CARBOPROST TROMETHAMINE | carboprost tromethamine | injection, solution, intramuscular | 81665-202ANDA |
| CROMOLYN SODIUM | CROMOLYN SODIUM | solution, concentrate, oral | 81665-104ANDA |
| Diethylpropion Hydrochloride ER | Diethylpropion Hydrochloride | tablet, extended release, oral | 81665-109ANDA |
| LEVETIRACETAM Extended-release | LEVETIRACETAM | tablet, extended release, oral | 81665-100ANDA |
| LEVETIRACETAM Extended-release | LEVETIRACETAM | tablet, extended release, oral | 81665-101ANDA |
| NUMBRINO | cocaine hydrochloride nasal | solution, topical | 81665-300NDA |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | sodium phenylacetate and sodium benzoate | injection, solution, concentrate, intravenous | 81665-203ANDA |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | sodium phenylacetate and sodium benzoate | injection, solution, concentrate, intravenous | 81665-204ANDA |
| Sodium Bicarbonate | SODIUM BICARBONATE | injection, solution, intravenous | 81665-200ANDA |
| cocaine hydrochloride nasal | cocaine hydrochloride nasal | solution, topical | 81665-301NDA AUTHORIZED GENERIC |
| isoniazid | isoniazid | tablet, oral | 81665-107ANDA |
| isoniazid | isoniazid | tablet, oral | 81665-108ANDA |
| isosorbide mononitrate | isosorbide mononitrate | tablet, oral | 81665-102NDA AUTHORIZED GENERIC |
| isosorbide mononitrate | isosorbide mononitrate | tablet, oral | 81665-103NDA AUTHORIZED GENERIC |
Compare
Other companies listing levetiracetam
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Hospira, Inc.7 sites · 332 NDC
- Fresenius Kabi USA, LLC6 sites · 561 NDC
- Torrent Pharma, Inc.5 sites · 184 NDC
- Micro Labs Limited5 sites · 141 NDC
- Pacific Medical Industries Ltd4 sites · 41 NDC
- Esteve Quimica, S.A.4 sites · 18 NDC
- QUAGEN PHARMACEUTICALS LLC2 sites · 50 NDC
- Wanbury Limited2 sites · 19 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
Enquiry
Common questions
- Is Omnivium Pharmaceuticals LLC FDA approved?
- Omnivium Pharmaceuticals LLC holds no registered establishment of its own; 14 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Omnivium Pharmaceuticals LLC make?
- 14 products are listed under Omnivium Pharmaceuticals LLC in the openFDA NDC Directory, most often as tablet; tablet, extended release; injection, solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.